Table 5.

Therapeutic control of blood pressure, cholesterol and glucose by gender

	Male (n=903)		Female (n=274)		P value
	n	% (95% CI)	n	% (95% CI)
Blood pressure*	899		258
BP at target 1†	595	69.9 (66.7 to 73.0)	187	72.4 (66.6 to 77.8)	0.43
BP at target 2‡	360	42.3 (39.0 to 45.7)	119	46.1 (39.9 to 52.4)	0.28
Cholesterol§	759		219
TC <5.0 mmol/L	698	92.0 (89.8 to 93.8)	184	84.0 (78.5 to 88.6)	<0.001
TC <4.0 mmol/L	523	68.9 (65.4 to 72.2)	104	47.5 (40.7 to 54.3)	<0.001
LDL <1.8 mmol/L¶	329	43.9 (40.3 to 47.6)	75	34.7 (28.4 to 41.5)	0.02
LDL <2.0 mmol/L¶	441	58.9 (55.3 to 62.4)	93	43.1 (36.4 to 49.9)	<0.001
LDL <3.0 mmol/L¶	695	92.8 (90.7 to 94.5)	193	89.4 (84.5 to 93.1)	0.10
Non-HDL <2.5 mmol/L	400	52.7 (49.1 to 56.3)	89	40.6 (34.1 to 47.4)	0.002
Glucose and BP control in diabetics**	209		58
Glucose <7 mmol/L††	61	30.4 (24.1 to 37.2)	16	29.1 (17.6 to 42.9)	0.86
HbA1c <7% (<53 mmol/mol)‡‡	107	54.9 (47.6 to 62.0)	29	50.0 (36.6 to 63.4)	0.51
HbA1c <6% (<42 mmol/mol)‡‡	29	14.9 (10.2 to 20.7)	9	15.5 (7.3 to 27.4)	0.90
BP at target‡	81	38.8 (32.1 to 45.7)	25	43.1 (30.2 to 56.8)	0.55

p values in bold indicate those with statistical significance

*Figures for those on blood pressure-lowering medication.

†Defined as blood pressure <140/90 mm Hg.

‡Defined as blood pressure <130/80 mm Hg.

§Figures for those on lipid-lowering medication and with cholesterol measurements made.

¶Data available for 749 male and 216 female patients.

**Figures for self-reported diabetics only.

††Data available for 201 male patients, 55 female.

‡‡Data available for 195 male patients, 58 female.

BP, blood pressure; HDL, high-density lipoprotein; LDL, high-density lipoprotein; TC, total cholesterol.